Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
Speaker
Prof. Charlotte Teunissen
Professor in Neurochemistry
Charlotte Teunissen’s drive is to improve the care of patients with neurological diseases by developing body fluid biomarkers for diagnosis, stratification, prognosis, and monitoring treatment responses.
Julius Clinical and Amsterdam UMC are proud to present the webinar:
Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
During this webinar, Charlotte Teunissen, Professor in Neurochemistry at Amsterdam UMC touched upon:
- Patient selection
- Patient stratification
- Outcome measures
Related webinars
Webinar – Improving ALS Trial Delivery Through Insights from Patient and Industry Experience
On January 19, at 16.30 CET, we will present the webinar: Improving ALS Trial Delivery Through Insights from Patient and Industry ExperienceWhat You’ll LearnPatient- and Industry-Informed Insights Top patient-experience pitfalls obs...
Webinar – Boosting patient enrolment and retention in clinical trials: Expert Insights & Tips
On June 30, at 16.00 CEST, we will present the webinar: Boosting patient enrolment and retention in clinical trials: Expert Insights & TipsJoin us for an interactive discussion with experts who will draw upon recent cardiology and neurolog...
Webinar: The Role of EEG in Dementia Trials
How early can you detect whether a treatment is working in dementia trials, and what if you didn’t have to wait for traditional endpoints? Electroencephalography (EEG) is gaining momentum as a powerful tool to capture real-time changes in brain...